Literature DB >> 15189952

Identification of spontaneous feline idiopathic pulmonary fibrosis: morphology and ultrastructural evidence for a type II pneumocyte defect.

Kurt Williams1, David Malarkey, Leah Cohn, Daniel Patrick, Janice Dye, Galen Toews.   

Abstract

STUDY
OBJECTIVES: Idiopathic pulmonary fibrosis (IPF) is a poorly understood chronic respiratory disease of humans, which has no correlate in other animals. Understanding the role that inflammation, alveolar epithelial cells, and myofibroblasts play in the progression of the disease is controversial, and hampered by the lack of an animal model. We have identified spontaneous IPF in domestic cats and hypothesized that this newly identified disease shares the pathology of human IPF; further, this work provides data suggesting that the disease is related to a defect in type II pneumocyte biology. SETTING AND
SUBJECTS: Chronic respiratory disease with pathology consistent with usual interstitial pneumonia (UIP) spontaneously developed in 16 domestic cats.
RESULTS: The histopathology of feline IPF consisted of the following: (1) interstitial fibrosis with fibroblast/myofibroblast foci, (2) honeycombing with alveolar epithelial metaplasia and type II pneumocyte hyperplasia, and (3) alveolar interstitial smooth-muscle metaplasia. Interstitial inflammation was not a prominent feature of the disease. alpha-Smooth muscle actin-positive myofibroblasts were prominent in myofibroblast foci, beneath honeycomb and hyperplastic epithelium, and in alveolar septa away from the remodeling. Feline IPF type II pneumocyte ultrastructure is similar to a heritable form of human IPF, with abnormal cytoplasmic lamellar body-like inclusions.
CONCLUSIONS: We conclude the following: (1) chronic respiratory disease with clinical and pathology features of UIP/IPF occurs in the domestic cat; (2) as in human IPF, the type II pneumocyte and myofibroblasts are important cellular constituents of feline IPF; and (3) type II cell ultrastructure suggests feline IPF is a defect in the type II pneumocyte.

Entities:  

Mesh:

Year:  2004        PMID: 15189952     DOI: 10.1378/chest.125.6.2278

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  7 in total

Review 1.  Viral infection and aging as cofactors for the development of pulmonary fibrosis.

Authors:  Payal K Naik; Bethany B Moore
Journal:  Expert Rev Respir Med       Date:  2010-12       Impact factor: 3.772

Review 2.  Stem Cell-Based Therapy in Idiopathic Pulmonary Fibrosis.

Authors:  Marek Barczyk; Matthias Schmidt; Sabrina Mattoli
Journal:  Stem Cell Rev Rep       Date:  2015-08       Impact factor: 5.739

3.  Clinical, computed tomographic and histopathological findings in two cats with pulmonary fibrosis of unknown aetiology.

Authors:  Eleanor C Duffy; Sally Griffin; Erin M O'Connell; Jeremy R Mortier
Journal:  JFMS Open Rep       Date:  2020-11-05

4.  An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis.

Authors:  R Gisli Jenkins; Bethany B Moore; Rachel C Chambers; Oliver Eickelberg; Melanie Königshoff; Martin Kolb; Geoffrey J Laurent; Carmel B Nanthakumar; Mitchell A Olman; Annie Pardo; Moises Selman; Dean Sheppard; Patricia J Sime; Andrew M Tager; Amanda L Tatler; Victor J Thannickal; Eric S White
Journal:  Am J Respir Cell Mol Biol       Date:  2017-05       Impact factor: 7.748

Review 5.  Exploring Animal Models That Resemble Idiopathic Pulmonary Fibrosis.

Authors:  Jun Tashiro; Gustavo A Rubio; Andrew H Limper; Kurt Williams; Sharon J Elliot; Ioanna Ninou; Vassilis Aidinis; Argyrios Tzouvelekis; Marilyn K Glassberg
Journal:  Front Med (Lausanne)       Date:  2017-07-28

6.  Perspectives in veterinary medicine: Description and classification of bronchiolar disorders in cats.

Authors:  Carol R Reinero; Isabelle Masseau; Megan Grobman; Aida Vientos-Plotts; Kurt Williams
Journal:  J Vet Intern Med       Date:  2019-04-13       Impact factor: 3.333

7.  Viruses as co-factors for the initiation or exacerbation of lung fibrosis.

Authors:  Kevin M Vannella; Bethany B Moore
Journal:  Fibrogenesis Tissue Repair       Date:  2008-10-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.